Free Trial

Oncotelic Therapeutics (OTLC) SEC Filings & 10K Form

Oncotelic Therapeutics logo
$0.03
+0.00 (+2.17%)
(As of 11/1/2024 08:57 PM ET)

Recent Oncotelic Therapeutics SEC Filings

DateFilerForm TypeView
08/27/2024
7:00 AM
Oncotelic Therapeutics, Inc. (Issuer)
Oncotelic Therapeutics (Issuer)
Trieu Vuong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
11:00 AM
Oncotelic Therapeutics, Inc. (Filer)
Oncotelic Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
6:15 AM
Oncotelic Therapeutics, Inc. (Filer)
Oncotelic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
11:15 PM
Oncotelic Therapeutics, Inc. (Filer)
Oncotelic Therapeutics (Filer)
Form EFFECT
04/18/2024
4:25 PM
Oncotelic Therapeutics, Inc. (Filer)
Oncotelic Therapeutics (Filer)
Form POS AM
04/12/2024
4:00 PM
Oncotelic Therapeutics, Inc. (Filer)
Oncotelic Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/12/2024
4:15 PM
Oncotelic Therapeutics, Inc. (Filer)
Oncotelic Therapeutics (Filer)
Form POS AM
02/02/2024
4:00 PM
Oncotelic Therapeutics, Inc. (Filer)
Oncotelic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:OTLC) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners